Our results showed that FLOT1, identified as a downstream factor of S100A11, enhanced the malignant properties of CRC cells and involved in EMT mediated by TGFβ/LASP1/S100A11 axis. The gene discussed is LASP1; the disease is colorectal carcinoma.